Isolation and expansion of human natural T regulatory cells for cellular therapy

Journal of Immunological Methods

Volumn 363, Issue 1, 2010, Pages 67-79

  Pahwa, Rajendra ^a   Jaggaiahgari, Shashidhar ^a   Pahwa, Savita ^a   Inverardi, Luca ^a   Tzakis, Andreas ^a   Ricordi, Camillo ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Expansion; IL 2; Natural T regulatory cells; Rapamycin; Suppression

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CELL ISOLATION; CELL THERAPY; CONTROLLED STUDY; EFFECTOR CELL; EX VIVO STUDY; FLOW CYTOMETRY; GRAFT REJECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY T LYMPHOCYTE; TH17 CELL;

ANTI-BACTERIAL AGENTS; CELL CULTURE TECHNIQUES; CELL SEPARATION; CYTOKINES; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INFLAMMATION MEDIATORS; LYMPHOCYTE TRANSFUSION; MALE; ORGAN TRANSPLANTATION; SIROLIMUS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 78649715490     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.10.006     Document Type: Article

References (41)

1. Appay V., van Lier R., Sallusto F., Roederer M. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008, 73:975.
2. Baecher-Allan C., Brown J., Freeman G., Hafler D. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 2001, 167:1245.
3. Banchereau J., Steinman R. Dendritic cells and the control of immunity. Nature 1998, 392:245.
4. Battaglia M., Stabilini A., Migliavacca B., Horejs-Hoeck J., Kaupper T., Roncarolo M. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 2006, 177:8338.
5. Bennett C., Christie J., Ramsdell F., Brunkow M., Ferguson P., Whitesell L., Kelly T., Saulsbury F., Chance P., Ochs H. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001, 27:20.
6. Brusko T., Hulme M., Myhr C., Haller M., Atkinson M. Assessing the in vitro suppressive capacity of regulatory T cells. Immunol. Invest. 2007, 36:607.
7. Chatila T., Blaeser F., Ho N., Lederman H., Voulgaropoulos C., Helms C., Bowcock A. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 2000, 106:R75.
8. Dardalhon V., Awasthi A., Kwon H., Galileos G., Gao W., Sobel R., Mitsdoerffer M., Strom T., Elyaman W., Ho I., Khoury S., Oukka M., Kuchroo V. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat. Immunol. 2008, 9:1347.
9. Darrah P., Patel D., De Luca P., Lindsay R., Davey D., Flynn B., Hoff S., Andersen P., Reed S., Morris S., Roederer M., Seder R. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 2007, 13:843.
10. Del Prete G., De Carli M., Almerigogna F., Giudizi M., Biagiotti R., Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 1993, 150:353.
11. Ding L., Linsley P., Huang L., Germain R., Shevach E. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 1993, 151:1224.
12. Fiorentino D., Bond M., Mosmann T. Two types of mouse T helper cell: IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989, 170:2081.
13. Fontenot J., Rudensky A. Molecular aspects of regulatory T cell development. Semin. Immunol. 2004, 16:73.
14. Fontenot J., Gavin M., Rudensky A. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4:330.
15. Godfrey W., Spoden D., Ge Y., Baker S., Liu B., Levine B., June C., Blazar B., Porter S. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005, 105:750.
16. Golovina T., Mikheeva T., Suhoski M., Aqui N., Tai V., Shan X., Liu R., Balcarcel R., Fisher N., Levine B., Carroll R., Warner N., Blazar B., June C., Riley J. CD28 costimulation is essential for human T regulatory expansion and function. J. Immunol. 2008, 181:2855.
17. Hippen K., Harker-Murray P., Porter S., Merkel S., Londer A., Taylor D., Bina M., Panoskaltsis-Mortari A., Rubinstein P., Van Rooijen N., Golovina T., Suhoski M., Miller J., Wagner J., June C., Riley J., Blazar B. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood 2008, 112:2847.
18. Hoffmann P., Eder R., Kunz-Schughart L., Andreesen R., Edinger M. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 2004, 104:895.
19. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057.
20. Kahan B., Camardo J. Rapamycin: clinical results and future opportunities. Transplantation 2001, 72:1181.
21. Khattri R., Cox T., Yasayko S., Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 2003, 4:337.
22. King C., Tangye S., Mackay C. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 2008, 26:741.
23. Kleinewietfeld M., Starke M., Di Mitri D., Borsellino G., Battistini L., Rötzschke O., Falk K. CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells. Blood 2009, 113:827.
24. Koppelman B., Neefjes J., de Vries J., de Waal Malefyt R. Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 1997, 7:861.
25. Kuniyasu Y., Takahashi T., Itoh M., Shimizu J., Toda G., Sakaguchi S. Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int. Immunol. 2000, 12:1145.
26. Lamoreaux L., Roederer M., Koup R. Intracellular cytokine optimization and standard operating procedure. Nat. Protoc. 2006, 1:1507.
27. Levings M., Sangregorio R., Sartirana C., Moschin A., Battaglia M., Orban P., Roncarolo M. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 2002, 196:1335.
28. Miyara M., Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 2007, 13:108.
29. Miyara M., Yoshioka Y., Kitoh A., Shima T., Wing K., Niwa A., Parizot C., Taflin C., Heike T., Valeyre D., Mathian A., Nakahata T., Yamaguchi T., Nomura T., Ono M., Amoura Z., Gorochov G., Sakaguchi S. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899.
30. Nagahama K., Nishimura E., Sakaguchi S. Induction of tolerance by adoptive transfer of Treg cells. Meth. Mol. Biol. 2007, 380:431.
31. Perfetto S., Chattopadhyay P., Roederer M. Seventeen-colour flow cytometry: unravelling the immune system. Nat. Rev. Immunol. 2004, 4:648.
32. Powell J., Lerner C., Schwartz R. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J. Immunol. 1999, 162:2775.
33. Putnam A., Brusko T., Lee M., Liu W., Szot G., Ghosh T., Atkinson M., Bluestone J. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 2009, 58:652.
34. Riley J., June C., Blazar B. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 2009, 30:656.
35. Roncarolo M., Bacchetta R., Bordignon C., Narula S., Levings M. Type 1 T regulatory cells. Immunol. Rev. 2001, 182:68.
36. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004, 22:531.
37. Sakaguchi S., Sakaguchi N., Shimizu J., Yamazaki S., Sakihama T., Itoh M., Kuniyasu Y., Nomura T., Toda M., Takahashi T. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 2001, 182:18.
38. Tran D., Andersson J., Hardwick D., Bebris L., Illei G., Shevach E. Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. Blood 2009, 113:5125.
39. Weiner H. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol. Rev. 2001, 182:207.
40. Wood K., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 2003, 3:199.
41. Zeiser R., Leveson-Gower D., Zambricki E., Kambham N., Beilhack A., Loh J., Hou J., Negrin R. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood 2008, 111:453.